U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals

Patent 5658583 Issued on August 19, 1997. Estimated Expiration Date: Icon_subject July 28, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

3929131

Transdermal delivery of drugs
Patent #: 4230105
Issued on: 10/28/1980
Inventor: Harwood

Therapeutic system for administering drugs to the skin
Patent #: 4286592
Issued on: 09/01/1981
Inventor: Chandrasekaran

Local anesthetic mixture for topical application and method for obtaining local anesthesia
Patent #: 4529601
Issued on: 07/16/1985
Inventor: Broberg ,   et al.

Patch
Patent #: 4685911
Issued on: 08/11/1987
Inventor: Konno ,   et al.

Two compartment mixing syringe
Patent #: 4693706
Issued on: 09/15/1987
Inventor: Ennis, III

Methods and instruments of moxibustion
Patent #: 4747841
Issued on: 05/31/1988
Inventor: Kuratomi ,   et al.

Temperature-controlled active agent dispenser
Patent #: 4830855
Issued on: 05/16/1989
Inventor: Stewart

Means for the application of transdermally absorbable active substances
Patent #: 4898592
Issued on: 02/06/1990
Inventor: Latzke, et al.

Monolithic user-activated transdermal therapeutic system
Patent #: 4911707
Issued on: 03/27/1990
Inventor: Heiber, et al.

More ...

Inventors

Application

No. 508463 filed on 07/28/1995

US Classes:

424/402, Wearing apparel, fabric, or cloth424/443, Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments424/447, Bandages with incorporated medicaments424/448, Pressure sensitive adhesive means424/449, Transdermal or percutaneous514/817, ANESTHETIC, TOPICAL514/937, DISPERSION OR EMULSION514/944, GEL602/41, BANDAGE STRUCTURE602/46Polymeric foam

Examiners

Primary: Phelan, D. Gabrielle

Attorney, Agent or Firm

Foreign Patent References

  • 2 163 956 GB. 03/13/1988
  • WO 88/09169 WO. 12/13/1988

International Class

A01N 025/34

Abstract

An apparatus, product formulation, and method for improved dermal permeation of pharmaceuticals wherein the apparatus includes a thin drug formulation reservoir and a heat-generating chamber separated by a first non-permeable wall, wherein the reservoir and chamber are formed in or supported by a housing. The drug formulation reservoir houses or is capable of housing a predetermined amount of a formulation containing pharmaceutically-active agent(s). The heat-generating/temperature-regulating chamber includes a medium for generating controlled heat, preferably a chemical composition made of carbon, iron, water and/or salt which is activated upon contact with air (oxygen). The function of the heat-generating/temperature-regulating element is to heat the user's skin, rapidly bring the skin temperature to a desired and elevated narrow range and keep it in this range for sufficient time to obtain more rapid, enhanced and less variable dermal absorption of selected pharmaceutically-active agents and to obtain improved clinical effects. Structure for controlling the generation of heat is also disclosed. The apparatus may optionally include a spacing or standoff structure which spans the drug formulation reservoir between the non-permeable wall and the user's skin surface for maintaining a predetermined thickness of the drug formulation on the user's skin surface. Also, a novel product formulation which can be used with the apparatus which uses high percentage of eutectic mixture of local anesthetics to reduce the overall degradation rate of the local anesthetic compound(s) in formulations which are subject to hydrolysis.

Other References

  • Mack Publishing Company, "Stability of Pharmaceutical Products", Pharmaceutical Sciences, pp. 1481-1482, 1985
  • McCafferty, et al., "Comparative In Vivo Assessment of the Percutaneous Absorption of Local Anaesthetics", Br. J. Anaesth., vol. 60, (1988), pp. 64-69
  • Woolfson, et al., "Concentration Response Analysis of Percutaneous Local Anaesthetic Formulations ", Br. J. Anaesth., vol. 61, (1988), pp. 590-592
  • McCafferty, et al., "In Vivo Assessment of Percutaneous Local Anaesthetic Preparations", Br. J. Anaesth., vol. 62, (1989), pp. 18-21
  • Knutson, et al., "Solvent-Mediated Alterations of the Stratum Corneum",Journal of Controlled Release, vol. 11, (1990), pp. 93-103
  • Lycka, "EMLA, A New and Effective Topical Anesthetic", J. Dermotol. Surg. Oncol., 18:859-862 (1992)
  • McCafferty, et al., "New Patch Delivery System for Percutaneous Local Anaesthesia", Br. J. Anaesth., 71:370-374 (1993)
  • Sakamoto, et al., "Dermal Patch Anaesthesia: Comparison of 10% Lignocaine Gel with Absorption Promoter and EMLA Cream", Anaesthesia, vol. 48, (1993), pp. 390-392
  • Woolfson, Percutaneous Local Anaesthesia, (1993), pp. 166-170
  • Astra USA, Inc., "EMLA Cream Product Information Form For American Hospital Formulary Service", 1993, pp. 1-2
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?